Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer.

Rolf GedeborgLars LindhagenStacy LoebJohan StyrkeHans GarmoPär Stattin

Published in: Scandinavian journal of urology (2021)

The increased mortality from COVID-19 in men with prostate cancer treated with ADT was mainly related to high age, comorbidity, and more advanced prostate cancer. There was no evidence to support the hypothesis that ADT is associated with improved COVID-19 outcomes.

Keyphrases

prostate cancer
coronavirus disease
sars cov
radical prostatectomy
cardiovascular events
respiratory syndrome coronavirus
risk factors
middle aged
papillary thyroid
type diabetes
mesenchymal stem cells
newly diagnosed
weight loss
replacement therapy